Proteomic urinary biomarker approach in renal disease: from discovery to implementation

Schanstra, J. P. and Mischak, H. (2015) Proteomic urinary biomarker approach in renal disease: from discovery to implementation. Pediatric Nephrology, 30(5), pp. 713-725. (doi: 10.1007/s00467-014-2790-y)

Full text not currently available from Enlighten.


Biomarkers hold the promise of significantly improving health care by enabling prognosis and diagnosis with improved accuracy, and at earlier points in time. Previous results have indicated that single biomarkers are not suitable to describe complex diseases such as kidney disease. Here we provide an update on the progress of urinary proteomics-based studies and strategies to develop biomarker-based classifiers that tolerate instability and inconsistency of individual biomarkers. The examples focus on two major fields in nephrology: chronic kidney disease in the adult population and obstructive nephropathies in the pediatric population. When employed adequately, urinary proteomics demonstrates a clear value in kidney disease, indicating that the current status quo ruling for decades now could be changed by applying modern “omics” approaches. However, while research is able to deliver these useful tools for patient management, the issues associated with implementation are not yet solved. Active engagement of the relevant clinical professional societies, aswell as patient’s organizations, might help to implement these omics approaches that have shown a clear benefit for the patient.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Mischak, Professor Harald
Authors: Schanstra, J. P., and Mischak, H.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Pediatric Nephrology
ISSN (Online):1432-198X

University Staff: Request a correction | Enlighten Editors: Update this record